---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-074446"
form_type: "8-K"
ticker: "VERA"
cik: "0001831828"
company_name: "Vera Therapeutics, Inc."
filed_at: "2025-05-19T23:59:59+00:00"
generated_at: "2026-05-21T02:04:01.108623+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Stockholders re-elect three Class I directors, ratify KPMG, and approve executive compensation on advisory basis

## Summary
- Elected three Class I directors (Fordyce, Seidenberg, Hall) each with >49M votes for, ~5.4M withheld, and 1.8M broker non-votes.
- Ratified KPMG LLP as auditor for FY2025 with 56.6M votes for and only 3,556 against.
- Advisory 'Say-on-Pay' approved with 52.98M votes for (96.6% of votes cast).
- Stockholders recommended annual advisory vote on executive compensation (54.8M votes for 'One Year'); company to hold annual votes.

## SEC filing metadata
- accession: 0000950170-25-074446
- form_type: 8-K
- ticker: VERA
- cik: 0001831828
- company_name: Vera Therapeutics, Inc.
- filed_at: 2025-05-19T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831828/000095017025074446/0000950170-25-074446-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831828/000095017025074446/vera-20250514.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-074446
- JSON: https://secwatch.observer/filing/0000950170-25-074446.json
- Plain text: https://secwatch.observer/filing/0000950170-25-074446.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.